Market News / Story
Bavarian Nordic A/S (BAVA) Hikes 2026 Outlook on Travel Health Strength
·
Bavarian Nordic A/S raised 2026 revenue guidance to ~DKK 6.1B and sees ~32% EBITDA margin, driven by stronger Travel Health sales, notably higher rabies vaccine demand in the U.S. Material Details #DetailAI Analyst View12026 revenue now ~DKK 6.1BHigher top-line outlook is an immediate positive for valuation and sentiment.2EBITDA margin now ~32%Improved profitability vs prior ~30% boosts earnings power.3Travel Health now ~DKK 3.4BSegment raised from ~DKK 3.0B; key driver…